December 2, 2011
Following international media reports that the US Food and Drug Administration (FDA) had denied approval for Ranbaxy Laboratories Ltd.’s generic version of Lipitor, Ranbaxy’s parent company Daiichi Sankyo scrambled on December 1 to confirm the facts. On the morning of...read more